Advertisement

Topics

ABIVAX Company Profile

16:09 EDT 18th August 2018 | BioPortfolio


News Articles [19 Associated News Articles listed on BioPortfolio]

DGAP-News: ABIVAX Eventplan (deutsch)

ABIVAX Eventplan DGAP-News: ABIVAX / Schlagwort(e): Konferenz ABIVAX Eventplan 12.03.2018 / 20:30 Für den Inhalt der Mitteilung ist der Emittent verantwortlich. -----------------------------------...

Abivax believes it has made progress towards HIV cure

Abivax has unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human...Read More... The post Abivax believes it has made progress towards HIV cure app...

Abivax completes dosing in ABX464-101 trial for UC

Abivax has completed dosing patients in the ABX464-101 trial, a Phase lla clinical trial investigating the safety and efficacy of...Read More... The post Abivax completes dosing in ABX464-101 trial fo...

Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

Abivax CEO outlines next moves after Phase IIa trial using ABX464 showed first proof in human of viral load reduction...    

ABIVAX Upcoming Events

2017 Financial Results to be announced on March 16, 2018 Regulatory News: ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 ABVX), a biotechnology company harnessing the immune system to develop a...

DGAP-News: ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab (deutsch)

ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab DGAP-News: ABIVAX / Schlagwort(e): Studie ABIVAX schließt Patien....

DGAP-News: ABIVAX ernennt Ian McGowan zum Vorsitzenden und Jürgen Rockstroh zum neuen Mitglied seines wissenschaftlichen Beirats (deutsch)

ABIVAX ernennt Ian McGowan zum Vorsitzenden und Jürgen Rockstroh zum neuen Mitglied seines wissenschaftlichen Beirats DGAP-News: ABIVAX / Schlagwort(e): Personalie ABIVAX ernennt Ian McGowan zum V...

Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member

Appointments Reflect Transition to Clinical Development Stage Company Regulatory News: ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 ABVX), a biotechnology company harnessing the immune system...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "ABIVAX" on BioPortfolio

We have published hundreds of ABIVAX news stories on BioPortfolio along with dozens of ABIVAX Clinical Trials and PubMed Articles about ABIVAX for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ABIVAX Companies in our database. You can also find out about relevant ABIVAX Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record